www.cms.gov
Open in
urlscan Pro
2a02:26f0:1700:384::28a
Public Scan
Submitted URL: https://lnks.gd/l/eyJhbGciOiJIUzI1NiJ9.eyJidWxsZXRpbl9saW5rX2lkIjoxMDEsInVyaSI6ImJwMjpjbGljayIsImJ1bGxldGluX2lkI...
Effective URL: https://www.cms.gov/outreach-and-educationoutreachffsprovpartprogprovider-partnership-email-archive/2022-05-26-mlnc
Submission: On May 26 via api from US — Scanned from DE
Effective URL: https://www.cms.gov/outreach-and-educationoutreachffsprovpartprogprovider-partnership-email-archive/2022-05-26-mlnc
Submission: On May 26 via api from US — Scanned from DE
Form analysis
2 forms found in the DOMGET /search/cms
<form action="/search/cms" method="get" id="search-block-form" accept-charset="UTF-8" class="search-form search-block-form">
<div class="js-form-item form-item js-form-type-search form-type-search js-form-item-keys form-item-keys form-no-label">
<label for="edit-keys--2" class="visually-hidden">Search</label>
<input title="Enter the terms you wish to search for." placeholder="Search CMS" aria-label="Search CMS" data-drupal-selector="edit-keys" type="search" id="edit-keys--2" name="keys" value="" size="15" maxlength="128" class="form-search">
</div>
<div data-drupal-selector="edit-actions" class="form-actions js-form-wrapper form-wrapper" id="edit-actions--2"><input data-drupal-selector="edit-submit" type="submit" id="edit-submit--3" value="Search" class="button js-form-submit form-submit">
</div>
</form>
POST https://public.govdelivery.com/accounts/USCMS/subscribers/qualify
<form accept-charset="UTF-8" action="https://public.govdelivery.com/accounts/USCMS/subscribers/qualify" id="email-footer-form" method="post" data-drupal-form-fields="email-footer-input,email-submit">
<div aria-label="Enter your email address for email updates" id="email-form"><input aria-label="Enter your email address:" name="email" placeholder="type your email here" type="text">
<input id="email-submit" name="email-footer-submit" type="submit" value="Submit">
</div>
</form>
Text Content
Skip to main content An official website of the United States government Here’s how you know Here’s how you know The .gov means it’s official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site. The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. HEADER * Home * About CMS * Newsroom * Archive * Help * Print Search SITE * Medicare * Medicaid/CHIP * Medicare-Medicaid Coordination * Private Insurance * Innovation Center * Regulations & Guidance * Research, Statistics, Data & Systems * Outreach & Education BREADCRUMB * Back to MLN Connects® Newsletter 2022-05-26-MLNC Date 2022-05-26 Subject Biosimilars: Interchangeable Products May Increase Patient Access Thursday, May 26, 2022 News * COVID-19: New Administration Code for Pfizer Pediatric Vaccine Booster Dose * Biosimilars: Interchangeable Products May Increase Patient Access * Critical Care Evaluation & Management Services: Comparative Billing Report in May Compliance * Surgical Dressings: Medicare Requirements Publications * Screening Pap Tests & Pelvic Exams — Revised NEWS COVID-19: NEW ADMINISTRATION CODE FOR PFIZER PEDIATRIC VACCINE BOOSTER DOSE On May 17, 2022, the FDA amended the Pfizer-BioNTech COVID-19 vaccine emergency use authorization (PDF) to authorize the use of a single booster pediatric dose (orange cap) for all patients 5–11 years old. CMS issued a new code, effective May 17, 2022, for the vaccine administration: Code: 0074A * Long descriptor: Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) (coronavirus disease [COVID-19]) vaccine, mRNALNP, spike protein, preservative free, 10 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation * Short descriptor: ADM SARSCV2 10MCG TRS-SUCR B For more information, visit the COVID-19 Provider Toolkit, and get the most current list of billing codes, payment allowances, and effective dates. (Note: you may need to refresh your browser if you recently visited these webpages). BIOSIMILARS: INTERCHANGEABLE PRODUCTS MAY INCREASE PATIENT ACCESS Depending on state pharmacy laws, you may substitute an interchangeable biosimilar product at the pharmacy, much like substituting a generic for a brand-name drug. This helps increase patient access to biologics and may reduce patient costs. Learn more about Interchangeable Biological Products from the FDA. Bookmark FDA’s Biosimilars webpage and materials for health care providers and patients. Additional FDA resources you may find helpful: * Overview of Biosimilar Products * Biosimilar Regulatory Review and Approval (PDF) CRITICAL CARE EVALUATION & MANAGEMENT SERVICES: COMPARATIVE BILLING REPORT IN MAY In late May, CMS will issue a Comparative Billing Report (CBR) on Medicare Part B claims for critical care evaluation and management services. Use the data-driven report to compare your billing practices with those of peers in your state and across the nation. CBRs aren’t publicly available. Look for an email from cbrpepper.noreply@religroupinc.com to access your report. Update your email address in PECOS to make sure you get it. More Information: * View a webinar recording * Visit the CBR website * Register for a live webinar on June 8 from 3–4 pm ET COMPLIANCE SURGICAL DRESSINGS: MEDICARE REQUIREMENTS Medicare covers primary or secondary surgical dressings: * When used to protect or treat a wound * If needed after you debride a wound You must: * Include clinical information in patients’ medical records that demonstrates a reasonable and necessary need for the type and quantity of surgical dressings * Evaluate the wound monthly and update the record, unless you document why you can't do a monthly evaluation and how you're monitoring the patient's ongoing use of dressings For more information, see the Surgical Dressings – Policy Article. PUBLICATIONS SCREENING PAP TESTS & PELVIC EXAMS — REVISED Learn about 3 new ICD-10 diagnosis codes for these screenings (PDF): * Z92.850 – Personal history of Chimeric Antigen Receptor T-cell therapy * Z92.858 – Personal history of other cellular therapy * Z92.86 – Personal history of gene therapy -------------------------------------------------------------------------------- Subscribe to the MLN Connects® newsletter. You can read previous issues in the archive. This newsletter is current as of the issue date. View the complete disclaimer. The Medicare Learning Network®, MLN Connects®, and MLN Matters® are registered trademarks of the U.S. Department of Health and Human Services (HHS). Home A federal government website managed and paid for by the U.S. Centers for Medicare & Medicaid Services. 7500 Security Boulevard, Baltimore, MD 21244 CMS & HHS WEBSITES * Medicare.gov * Medicaid.gov * InsureKidsNow.gov * HealthCare.gov * HHS.gov/Open TOOLS * Acronyms * Archive * Contacts * Glossary HELPFUL LINKS * Web Policies & Important Links * Careers * For Developers * Plain Language * Privacy Policy * Privacy Settings * Freedom of Information Act * No Fear Act * Nondiscrimination/Accessibility * HHS.gov * Inspector General * USA.gov * Help with file formats & plug-ins RECEIVE EMAIL UPDATES CONNECT WITH CMS * Twitter link * Youtube link * Facebook link * Linkedin link * RSS Feed link Feedback